Adjuvant effect of antimicrobial photodynamic therapy (aPDT) in the treatment of diabetic foot ulcers: A case series

This study aimed to evaluate the clinical evolution of patients with diabetic foot ulcer treated with antimicrobial photodynamic therapy (aPDT) using the Bates‐Jensen (BJ) scale. A total of 21 patients were monitored, with an average age of 58 years. Patients underwent the standard treatment protoco...

Full description

Saved in:
Bibliographic Details
Published inJournal of biophotonics Vol. 17; no. 4; pp. e202300412 - n/a
Main Authors Ferreira, Rita de Cassia, Cecatto, Rebeca Boltes, Perez, Silvana Torres, Mesquita‐Ferrari, Raquel Agnelli, Bussadori, Sandra Kalil, Duran, Cinthya Cosme, Horliana, Anna Carolina Tempestini, Fernandes, Kristianne Porta Santos
Format Journal Article
LanguageEnglish
Published Weinheim WILEY‐VCH Verlag GmbH & Co. KGaA 01.04.2024
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This study aimed to evaluate the clinical evolution of patients with diabetic foot ulcer treated with antimicrobial photodynamic therapy (aPDT) using the Bates‐Jensen (BJ) scale. A total of 21 patients were monitored, with an average age of 58 years. Patients underwent the standard treatment protocol of the institution, supplemented with aPDT utilizing 0.01% methylene blue (MB) and laser irradiation (660 nm, 100 mW, 6 J per point). Following aPDT, the lesions were protected with hydrofiber dressings containing silver. The Bates‐Jensen Scale was employed at pre‐treatment and post‐aPDT sessions to assess lesion progression. The results demonstrated a significant difference between pre‐ and post‐treatment values in the overall BJ score. The use of MB in aPDT proved to be an effective, safe, well‐tolerated treatment with high patient adherence and the potential for implementation in the care of diabetic foot conditions. DFU exhibit challenging healing processes. aPDT accelerated the process of healing in DFU. aPDT can be a non‐invasive, safe, and cost‐effective adjunctive therapy for treating DFU.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1864-063X
1864-0648
1864-0648
DOI:10.1002/jbio.202300412